{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:49:16Z","timestamp":1780584556833,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jcv.2022.105159","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T21:25:56Z","timestamp":1649798756000},"page":"105159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment"],"prefix":"10.1016","volume":"150-151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2998-3149","authenticated-orcid":false,"given":"Anni","family":"Winckelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Fahn\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka Shukla","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus Illum","family":"Dalegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lundh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Ryom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2022.105159_bib0001","article-title":"Global Hepatitis Report","year":"2017","journal-title":"Glob. Hepat. Rep."},{"key":"10.1016\/j.jcv.2022.105159_bib0002","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105159_bib0003","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"EASL","year":"2017","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jcv.2022.105159_bib0004","first-page":"116","article-title":"Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance","volume":"33","author":"Zoulim","year":"2013","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver."},{"key":"10.1016\/j.jcv.2022.105159_bib0005","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2022.105159_bib0006","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/jhep.2000.19619","article-title":"Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B","volume":"32","author":"Nafa","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105159_bib0007","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2022.105159_bib0008","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2022.105159_bib0009","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.21422","article-title":"Entecavir resistance is rare in nucleoside na\u00efve patients with hepatitis B","volume":"44","author":"Colonno","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105159_bib0010","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.22790","article-title":"The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains","volume":"49","author":"Amini-Bavil-Olyaee","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105159_bib0011","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2019.02.006","article-title":"Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients","volume":"70","author":"Park","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105159_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jvh.13397","article-title":"Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance","volume":"28","author":"Liu","year":"2021","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jcv.2022.105159_bib0013","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.30647","article-title":"Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants","volume":"70","author":"Jensen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105159_bib0014","doi-asserted-by":"crossref","first-page":"D566","DOI":"10.1093\/nar\/gks1022","article-title":"HBVdb: a knowledge database for Hepatitis B Virus","volume":"41","author":"Hayer","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"10.1016\/j.jcv.2022.105159_bib0015","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S1386-6532(05)80015-0","article-title":"Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes","volume":"34","author":"Buti","year":"2005","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.jcv.2022.105159_bib0016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12688\/wellcomeopenres.15992.1","article-title":"Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms","volume":"5","author":"Mokaya","year":"2020","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jcv.2022.105159_bib0017","first-page":"2106","article-title":"No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B","volume":"12","author":"Corsa","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.jcv.2022.105159_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.12688\/wellcomeopenres.9952.1","article-title":"Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virus","volume":"1","author":"Lumley","year":"2016","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jcv.2022.105159_bib0019","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1301507","article-title":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity","volume":"191","author":"Rivino","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2022.105159_bib0020","first-page":"1868","article-title":"Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection","volume":"39","author":"Marcellin","year":"2019","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver."},{"key":"10.1016\/j.jcv.2022.105159_bib0021","doi-asserted-by":"crossref","first-page":"15574","DOI":"10.1038\/s41598-020-72467-9","article-title":"Complex genetic encoding of the hepatitis B virus on-drug persistence","volume":"10","author":"Thai","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:16:24Z","timestamp":1761362184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653222000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":21,"alternative-id":["S1386653222000920"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105159","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105159"}}